ADAD1
geneOn this page
Also known as Tenr
Summary
ADAD1 (adenosine deaminase domain containing 1, HGNC:30713) is a protein-coding gene on chromosome 4q27, encoding Adenosine deaminase domain-containing protein 1 (Q96M93). Required for male fertility and normal male germ cell differentiation.
Predicted to enable double-stranded RNA adenosine deaminase activity; double-stranded RNA binding activity; and tRNA-specific adenosine deaminase activity. Predicted to be involved in RNA processing and adenosine to inosine editing. Predicted to act upstream of or within spermatid development. Predicted to be located in male germ cell nucleus. Predicted to be active in cytoplasm and nucleolus.
Source: NCBI Gene 132612 — RefSeq curated summary.
At a glance
- GWAS associations: 34
- Clinical variants (ClinVar): 67 total
- MANE Select transcript:
NM_139243
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30713 |
| Approved symbol | ADAD1 |
| Name | adenosine deaminase domain containing 1 |
| Location | 4q27 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Tenr |
| Ensembl gene | ENSG00000164113 |
| Ensembl biotype | protein_coding |
| OMIM | 614130 |
| Entrez | 132612 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 5 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000296513, ENST00000388724, ENST00000388725, ENST00000439307, ENST00000446706, ENST00000464160, ENST00000492454
RefSeq mRNA: 3 — MANE Select: NM_139243
NM_001159285, NM_001159295, NM_139243
CCDS: CCDS34058, CCDS54800, CCDS54801
Canonical transcript exons
ENST00000296513 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001081556 | 122429626 | 122429784 |
| ENSE00001081557 | 122415379 | 122415616 |
| ENSE00001081558 | 122411222 | 122411392 |
| ENSE00001081560 | 122421261 | 122421390 |
| ENSE00001081561 | 122412580 | 122412809 |
| ENSE00001081563 | 122407908 | 122408031 |
| ENSE00001081566 | 122380062 | 122380241 |
| ENSE00001369233 | 122379372 | 122379445 |
| ENSE00001389701 | 122379011 | 122379115 |
| ENSE00003517166 | 122383799 | 122383966 |
| ENSE00003533480 | 122380992 | 122381180 |
| ENSE00003651231 | 122393589 | 122393657 |
| ENSE00003788695 | 122396252 | 122396377 |
Expression profiles
Bgee: expression breadth broad, 46 present calls, max score 98.96.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2103 / max 176.3742, expressed in 6 samples.
FANTOM5 promoters (10 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 49535 | 0.1222 | 5 |
| 49530 | 0.0281 | 3 |
| 49532 | 0.0125 | 3 |
| 49528 | 0.0119 | 3 |
| 49536 | 0.0089 | 3 |
| 49534 | 0.0074 | 3 |
| 49531 | 0.0071 | 3 |
| 49529 | 0.0059 | 3 |
| 49533 | 0.0045 | 3 |
| 49537 | 0.0020 | 2 |
Top tissues by expression
199 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 98.96 | gold quality |
| secondary oocyte | CL:0000655 | 97.82 | gold quality |
| left testis | UBERON:0004533 | 95.79 | gold quality |
| adult organism | UBERON:0007023 | 95.78 | gold quality |
| oocyte | CL:0000023 | 95.75 | gold quality |
| right testis | UBERON:0004534 | 95.49 | gold quality |
| testis | UBERON:0000473 | 93.64 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.49 | gold quality |
| tibialis anterior | UBERON:0001385 | 83.88 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.59 | gold quality |
| buccal mucosa cell | CL:0002336 | 81.65 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 72.97 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 72.82 | gold quality |
| ileal mucosa | UBERON:0000331 | 71.79 | silver quality |
| pancreatic ductal cell | CL:0002079 | 71.06 | silver quality |
| myocardium | UBERON:0002349 | 60.17 | gold quality |
| upper leg skin | UBERON:0004262 | 59.47 | silver quality |
| skin of hip | UBERON:0001554 | 56.70 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 55.99 | gold quality |
| quadriceps femoris | UBERON:0001377 | 55.50 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 54.62 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| vastus lateralis | UBERON:0001379 | 53.35 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 52.28 | gold quality |
| gingival epithelium | UBERON:0001949 | 50.51 | gold quality |
| cardia of stomach | UBERON:0001162 | 49.40 | gold quality |
| gingiva | UBERON:0001828 | 47.27 | gold quality |
| cauda epididymis | UBERON:0004360 | 46.54 | gold quality |
| superior surface of tongue | UBERON:0007371 | 46.40 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 28.99 |
| E-ANND-3 | yes | 3.92 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 4)
- Genetic variation in a linkage disequilibrium block encompassing the KIAA1109-TENR-IL2-IL21 genes predisposes to celiac disease. (PMID:17558408)
- Using a family-based study, we have provided a trend for the association of the KIAA1109/Tenr/IL2/IL21 gene region with rheumatoid arthritis in populations of European descent (PMID:19302705)
- The KIAA1109-TENR-IL2-IL21 gene cluster, that encodes an interleukin (IL-21) that plays an important role in Th17 cell biology, is the 20th locus for which there is a genome-wide level of support for association with rheumatoid arthritis. (PMID:20553587)
- ADAD1_rs17388568 AA was associated with a lower risk of having joints with Limitation of motion in patients with Juvenile Idiopathic Arthritis. (PMID:28145159)
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | adad1 | ENSDARG00000089181 |
| mus_musculus | Adad1 | ENSMUSG00000027719 |
| rattus_norvegicus | Adad1 | ENSRNOG00000017246 |
| drosophila_melanogaster | loqs | FBGN0032515 |
| drosophila_melanogaster | CG12493 | FBGN0035571 |
| drosophila_melanogaster | blanks | FBGN0035608 |
| drosophila_melanogaster | Zn72D | FBGN0263603 |
| caenorhabditis_elegans | zfr-1 | WBGENE00022388 |
Paralogs (14): STAU2 (ENSG00000040341), ZFR (ENSG00000056097), ADAT1 (ENSG00000065457), ZFR2 (ENSG00000105278), STAU1 (ENSG00000124214), ILF3 (ENSG00000129351), TARBP2 (ENSG00000139546), ADAD2 (ENSG00000140955), ILF2 (ENSG00000143621), ADAR (ENSG00000160710), STRBP (ENSG00000165209), PRKRA (ENSG00000180228), ADARB2 (ENSG00000185736), ADARB1 (ENSG00000197381)
Protein
Protein identifiers
Adenosine deaminase domain-containing protein 1 — Q96M93 (reviewed: Q96M93)
Alternative names: Testis nuclear RNA-binding protein
All UniProt accessions (4): A0A140VKH5, C9JAT9, C9JGM6, Q96M93
UniProt curated annotations — full annotation on UniProt →
Function. Required for male fertility and normal male germ cell differentiation. Plays a role in spermatogenesis. Binds to RNA but not to DNA.
Subcellular location. Nucleus.
Similarity. Belongs to the ADAD family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96M93-1 | 1 | yes |
| Q96M93-2 | 2 | |
| Q96M93-3 | 3 |
RefSeq proteins (3): NP_001152757, NP_001152767, NP_640336* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002466 | A_deamin | Domain |
| IPR014720 | dsRBD_dom | Domain |
| IPR044455 | ADAD1_DSRM | Domain |
Pfam: PF00035, PF02137
UniProt features (7 total): domain 2, splice variant 2, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96M93-F1 | 78.19 | 0.50 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 62 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, GOBP_MALE_GAMETE_GENERATION, GOBP_RNA_MODIFICATION, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOCC_NUCLEOLUS, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES, MATZUK_SPERMATOZOA, GOMF_ADENOSINE_DEAMINASE_ACTIVITY, GOMF_DEAMINASE_ACTIVITY, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS, MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED, MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED, GOBP_ADENOSINE_TO_INOSINE_EDITING
GO Biological Process (5): adenosine to inosine editing (GO:0006382), RNA processing (GO:0006396), spermatid development (GO:0007286), spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (5): double-stranded RNA binding (GO:0003725), double-stranded RNA adenosine deaminase activity (GO:0003726), tRNA-specific adenosine deaminase activity (GO:0008251), RNA binding (GO:0003723), adenosine deaminase activity (GO:0004000)
GO Cellular Component (4): male germ cell nucleus (GO:0001673), nucleolus (GO:0005730), cytoplasm (GO:0005737), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| deaminase activity | 2 |
| base conversion or substitution editing | 1 |
| gene expression | 1 |
| RNA biosynthetic process | 1 |
| primary metabolic process | 1 |
| germ cell development | 1 |
| spermatid differentiation | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| RNA binding | 1 |
| adenosine deaminase activity | 1 |
| catalytic activity, acting on a tRNA | 1 |
| nucleic acid binding | 1 |
| hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 1 |
| germ cell nucleus | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
944 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ADAD1 | BLTP1 | Q2LD37 | 959 |
| ADAD1 | TAGAP | Q8N103 | 680 |
| ADAD1 | MYO9B | Q13459 | 639 |
| ADAD1 | SH2B3 | Q9UQQ2 | 632 |
| ADAD1 | IL2 | P01585 | 616 |
| ADAD1 | IL18R1 | Q13478 | 549 |
| ADAD1 | TOR1A | O14656 | 544 |
| ADAD1 | RGS1 | Q08116 | 530 |
| ADAD1 | ADA | P00813 | 493 |
| ADAD1 | TSNAXIP1 | Q2TAA8 | 490 |
| ADAD1 | NAA25 | Q14CX7 | 479 |
| ADAD1 | Q5Y7H0 | Q5Y7H0 | 459 |
| ADAD1 | CHCHD1 | Q96BP2 | 458 |
| ADAD1 | FBLL1 | A6NHQ2 | 457 |
| ADAD1 | PTPN2 | P17706 | 449 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0JM23, A0JMU5, D3ZVK1, E1BPX4, E9PXF8, E9Q956, G5EF51, P0CI65, P49717, P57075, P81128, P83509, Q008S8, Q0V9Q6, Q16K67, Q1RMS6, Q32NG0, Q32NR9, Q3EBC8, Q3V3E1, Q4G0Z9, Q5N870, Q5R6Y2, Q5XI14, Q5ZL91, Q66IW8, Q692V3, Q6AZT7, Q6DIR8, Q6NTN5, Q6P2P2, Q6P2S7, Q6P5D8, Q6ZS30, Q7TQK1, Q7Z392, Q7Z494, Q80VJ4, Q8BGG7, Q8C0L9
Diamond homologs: A0A7H0DN38, A8EV88, P19525, P21081, P21605, P33863, P55265, P55266, Q32NG0, Q3KR54, Q5SUE7, Q63184, Q96M93, Q99MU3, Q9DHS8, O42912, Q28FE8, Q4R7N3, Q5ZI16, Q9BUB4, Q9JHI2, Q9U3D6, Q8NCV1, Q95JV3, Q9D5P4, P51400, Q54XP3, Q9NS39, Q9V3R6, P97616, Q22618, Q9JI20, F4HU58, Q91ZS8, B9KGT5, P78563, Q08E27, Q12906, Q2GIW0, Q5P9U8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
67 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 64 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2076 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:122380239:CGG:C | donor_loss | 1.0000 |
| 4:122380240:GG:G | donor_gain | 1.0000 |
| 4:122380241:GG:G | donor_gain | 1.0000 |
| 4:122380241:GGTA:G | donor_loss | 1.0000 |
| 4:122380242:G:GG | donor_gain | 1.0000 |
| 4:122380242:G:T | donor_loss | 1.0000 |
| 4:122380243:T:A | donor_loss | 1.0000 |
| 4:122380990:A:AG | acceptor_gain | 1.0000 |
| 4:122380990:AG:A | acceptor_gain | 1.0000 |
| 4:122380991:G:A | acceptor_loss | 1.0000 |
| 4:122380991:G:GG | acceptor_gain | 1.0000 |
| 4:122380991:GG:G | acceptor_gain | 1.0000 |
| 4:122380991:GGT:G | acceptor_gain | 1.0000 |
| 4:122380991:GGTA:G | acceptor_gain | 1.0000 |
| 4:122380991:GGTAA:G | acceptor_gain | 1.0000 |
| 4:122381165:G:GT | donor_gain | 1.0000 |
| 4:122381166:A:T | donor_gain | 1.0000 |
| 4:122381179:AGG:A | donor_loss | 1.0000 |
| 4:122381180:GGCA:G | donor_loss | 1.0000 |
| 4:122381181:GCAA:G | donor_loss | 1.0000 |
| 4:122381185:GT:G | donor_gain | 1.0000 |
| 4:122381190:AAATT:A | donor_gain | 1.0000 |
| 4:122383835:T:TA | acceptor_gain | 1.0000 |
| 4:122383965:AGGT:A | donor_loss | 1.0000 |
| 4:122383967:GTA:G | donor_loss | 1.0000 |
| 4:122383968:T:A | donor_loss | 1.0000 |
| 4:122396250:AGAAG:A | acceptor_gain | 1.0000 |
| 4:122396251:GAA:G | acceptor_gain | 1.0000 |
| 4:122396251:GAAGG:G | acceptor_gain | 1.0000 |
| 4:122407902:TTTCA:T | acceptor_loss | 1.0000 |
AlphaMissense
3775 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:122381118:C:A | A100D | 0.999 |
| 4:122381121:T:C | L101S | 0.999 |
| 4:122383819:T:C | F128L | 0.999 |
| 4:122383821:T:A | F128L | 0.999 |
| 4:122383821:T:G | F128L | 0.999 |
| 4:122383832:C:A | A132D | 0.999 |
| 4:122383878:A:C | K147N | 0.999 |
| 4:122383878:A:T | K147N | 0.999 |
| 4:122383897:G:C | A154P | 0.999 |
| 4:122383898:C:A | A154E | 0.999 |
| 4:122383900:G:C | A155P | 0.999 |
| 4:122383901:C:A | A155E | 0.999 |
| 4:122383910:C:A | A158D | 0.999 |
| 4:122383913:T:C | L159P | 0.999 |
| 4:122381087:T:G | Y90D | 0.998 |
| 4:122381117:G:C | A100P | 0.998 |
| 4:122383862:G:A | G142E | 0.998 |
| 4:122383868:G:A | G144E | 0.998 |
| 4:122421292:A:C | S507R | 0.998 |
| 4:122421294:T:A | S507R | 0.998 |
| 4:122421294:T:G | S507R | 0.998 |
| 4:122421303:T:G | C510W | 0.998 |
| 4:122383861:G:A | G142R | 0.997 |
| 4:122383861:G:C | G142R | 0.997 |
| 4:122383867:G:A | G144R | 0.997 |
| 4:122383867:G:C | G144R | 0.997 |
| 4:122383868:G:T | G144V | 0.997 |
| 4:122383876:A:G | K147E | 0.997 |
| 4:122383885:T:C | S150P | 0.997 |
| 4:122383909:G:C | A158P | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000235563 (4:122406031 A>C), RS1000346001 (4:122413304 G>A), RS1000385824 (4:122426273 A>C), RS1000475149 (4:122406985 A>G,T), RS1000541238 (4:122388217 C>A,T), RS1000541577 (4:122399254 T>G), RS1000608671 (4:122426385 T>C), RS1000656486 (4:122381854 G>A,T), RS1000696504 (4:122413666 A>G), RS1000768550 (4:122388257 G>A), RS1000773731 (4:122377071 C>T), RS1000806481 (4:122405701 C>G,T), RS1000869815 (4:122395032 C>CTA,CTATA), RS1001028644 (4:122401673 T>C), RS1001062256 (4:122419323 A>G)
Disease associations
OMIM: gene MIM:614130 | disease phenotypes: MIM:616577
GenCC curated gene-disease
Mondo (1): microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome (MONDO:0014698)
Orphanet (1): Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome (Orphanet:457351)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
34 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000048_2 | Celiac disease | 1.000000e-14 |
| GCST000157_8 | Celiac disease | 3.000000e-13 |
| GCST000964_33 | Ulcerative colitis | 9.000000e-07 |
| GCST001191_3 | Type 1 diabetes | 6.000000e-06 |
| GCST002083_16 | Self-reported allergy | 4.000000e-08 |
| GCST002084_6 | Allergic sensitization | 6.000000e-10 |
| GCST002520_7 | Celiac disease | 3.000000e-11 |
| GCST004131_73 | Inflammatory bowel disease | 1.000000e-07 |
| GCST004132_89 | Crohn’s disease | 9.000000e-07 |
| GCST004644_1 | Vaso-occlusive pain in sickle-cell anemia | 6.000000e-08 |
| GCST004866_24 | Alopecia areata | 1.000000e-06 |
| GCST005038_39 | Allergic disease (asthma, hay fever or eczema) | 9.000000e-27 |
| GCST005523_20 | Celiac disease | 2.000000e-38 |
| GCST007563_21 | Allergic disease (asthma, hay fever or eczema) | 4.000000e-10 |
| GCST007564_10 | Asthma or allergic disease (pleiotropy) | 3.000000e-12 |
| GCST007797_30 | Asthma onset (childhood vs adult) | 5.000000e-08 |
| GCST007798_66 | Asthma | 2.000000e-21 |
| GCST007798_67 | Asthma | 2.000000e-18 |
| GCST007799_43 | Asthma (adult onset) | 8.000000e-10 |
| GCST007799_46 | Asthma (adult onset) | 2.000000e-10 |
| GCST007800_24 | Asthma (childhood onset) | 6.000000e-36 |
| GCST007994_15 | Asthma (age of onset) | 8.000000e-06 |
| GCST007995_16 | Asthma (childhood onset) | 2.000000e-14 |
| GCST008103_153 | Bipolar disorder | 5.000000e-06 |
| GCST008489_18 | Celiac disease | 1.000000e-08 |
| GCST008916_105 | Asthma | 1.000000e-12 |
| GCST008916_118 | Asthma | 4.000000e-15 |
| GCST008916_22 | Asthma | 2.000000e-08 |
| GCST009719_22 | Allergic rhinitis | 5.000000e-15 |
| GCST009720_99 | Asthma | 5.000000e-20 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005298 | allergic sensitization measurement |
| EFO:0008316 | vaso-occlusive pain measurement |
| EFO:0004847 | age at onset |
| EFO:1002011 | adult onset asthma |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| (+)-JQ1 compound | decreases expression | 1 |
| MT19c compound | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Polychlorinated Biphenyls | affects expression | 1 |
| Theophylline | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): allergic rhinitis, alopecia areata, microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome